Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Orchestra BioMed’s Breakthrough Device designation could apply to nearly 8 million patients with uncontrolled hypertension and increased cardiovascular risk

FDA Awards Breakthrough Device Designation to AVIM Therapy for Hypertension

Anemia can moderate the association between both conditions, increasing the risk of atherosclerotic cardiovascular disease.

Anemia Exacerbates Adverse Effects of Hypertension and Blood Urea Nitrogen

Bhatt discusses his expectations for the future of cardiology in 2025, including GLP-1-RAs and the push towards combination therapy.

GLP-1 RAs and the Move to Combination Therapy in 2025, with Ankeet Bhatt, MD, MBA

Ruff discusses his expectations for cardiology for the rest of 2025, including new research into GLP-1 receptor agonists.

GLP-1 RAs and the Future of Cardiology, with Christian Ruff, MD, MPH

Le discusses his anticipation for the results of upcoming cardiology trials in 2025, including HORIZON and Target-D.

Latest in Lipids and Trials to Watch in 2025, with Viet Le, DMSc, PA-C

Our Q1 2025 recap for cardiology spotlights 6 regulatory updates, 5 key trial announcements, and top expert perspectives in cardiac care.



Q1 2025 Recap: Cardiology News and Updates

A recap of 10 clinical trials in cardiovascular care to know from the American College of Cardiology 2025 Scientific Sessions. 

ACC 2025 Recap: 10 Trials to Know

Patients with PAH saw a 76% reduction in the composite of morbidity and mortality outcomes with sotatercept treatment.

Sotatercept Lowers Risk of Major PAH Outcomes in Phase 3 ZENITH Trial

Vallerie Mclaughlin, MD, discusses the ZENITH trial and its historic effects of sotatercept on mortality, transplant risk, and more in PAH.

ZENITH Shows Sotatercept Reduces Mortality, Transplant Risk in PAH, with Vallerie Mclaughlin, MD

Lorundrostat Improves Blood Pressure in Uncontrolled Hypertension

The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.